FDA Drug Recalls

Recalls / Class II

Class IID-1409-2019

Product

Cetirizine Oral Solution 1 mg/mL, Up & Up, Children's allergy relief, Antihistamine, Dye Free, Grape Flavor, 4 FL. oz. (118 mL) Bottle, Distributed by Target Corporation, Minneapolis, MN 55403, NDC 11673-178-04, UPC 359726178044.

Affected lot / code info
Lot #s: A98495; C03882; A49664, Exp. 5/19; C06541, Exp. 6/19; C05532; F00527, Exp. 10/19; F00528; F07279, Exp. 12/19; F07842; F10237, Exp. 2/20.

Why it was recalled

cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Recalling firm

Firm
P & L Developments, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
200 Hicks St, N/A, Westbury, New York 11590-3323

Distribution

Quantity
124,512 bottles
Distribution pattern
Nationwide in the U.S.

Timeline

Recall initiated
2019-06-05
FDA classified
2019-06-20
Posted by FDA
2019-06-26
Terminated
2020-09-09
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1409-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls